Shanghai MicroPort Endovascular MedTech Co., Ltd. (SHA:688016)

Market Cap	10.73B
Revenue (ttm)	1.18B
Net Income (ttm)	447.44M
Shares Out	121.31M
EPS (ttm)	3.62
PE Ratio	24.42
Forward PE	17.42
Dividend	2.01 (2.21%)
Ex-Dividend Date	Jun 6, 2025

Volume	2,028,401
Average Volume	1,357,857
Open	90.17
Previous Close	90.92
Day's Range	88.15 - 90.72
52-Week Range	78.62 - 135.58
Beta	0.06
RSI	50.58
Earnings Date	Aug 26, 2025

About SHA:688016

Shanghai MicroPort Endovascular MedTech Co., Ltd. engages in the research and development, manufacturing, and sale of aortic and peripheral vascular medical devices in China and internationally. The company’s products include branched aortic stent graft system, thoracic stent graft system, abdominal aortic stent graft and delivery system, bifurcated stent graft system, and other stent graft system in surgical operation, as well as accessories, such as balloon inflation catheter. Shanghai MicroPort Endovascular MedTech Co., Ltd. was incorporated...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2012
• Employees: 826
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688016

Financial Performance

In 2024, SHA:688016's revenue was 1.21 billion, an increase of 1.61% compared to the previous year's 1.19 billion. Earnings were 502.10 million, an increase of 1.96%.